22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › COGENT BIOSCIENCES INC. › 2024-2025

COGENT BIOSCIENCES INC. 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and COGENT BIOSCIENCES INC.’s Form 8-K, filed June 5, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 5Ballot items
  • 173Asset managers, any item
  • 935Fund votes
  • June 4, 2025Meeting date

Results at a glance

Meeting of June 4, 2025: 5 items on COGENT BIOSCIENCES INC.’s Form 8-K, filed June 5, 2025: 2 elected · 3 passed (calculated).

Dissent

Significant dissent: 1 director (24.5% against).

Notable dissent: 1 director (14.8% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore COGENT BIOSCIENCES INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by COGENT BIOSCIENCES INC.

These tallies are COGENT BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

COGENT BIOSCIENCES INC. — official shareholder meeting results, meeting held June 4, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Dr. Karen Ferrante 68,418,781---- 22,231,56410,575,051 75%Elected—
Elect Director: Matthew E. Ros 77,274,345---- 13,376,00010,575,051 85%Elected—
2. Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm 101,115,649104,2685,479 --0 99.9%Passed (calculated)—
3. Advisory Vote on Executive Compensation 89,797,699808,71543,931 --10,575,051 99.1%Passed (calculated)—
4. Approval of an Amendment to the Certificate of Incorporation to Provide for Officer Exculpation 86,181,3734,422,46246,510 --10,575,051 95%Passed (calculated)—

Source: COGENT BIOSCIENCES INC., Form 8-K, filed with the SEC on June 5, 2025 — read the filing on EDGAR.

How asset managers voted at the COGENT BIOSCIENCES INC. 2024-2025 meeting

173 asset managers disclosed a vote on at least one COGENT BIOSCIENCES INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Dr. Karen Ferrante

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

75% Majority: yes · of votes cast

FOR 75%WITHHELD
FOR: 68,418,781WITHHELD: 22,231,564
Details: description as filed, official tally, votes by 45 asset managers

Description as filed by funds: Election of the two Class I director nominees to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dr. Karen Ferrante

COGENT BIOSCIENCES INC.’s own tally for this item (“Elect Director: Dr. Karen Ferrante”): 68,418,781 for, 22,231,564 withheld, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, each of the Company's director nominees was elected and each of the other proposals voted on were approved.”
Support: 75% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 27,824,681 for, 3,382,149 withheld, 216,053 abstained.

FOR
FOR: 27,824,681ABSTAIN: 216,053WITHHOLD: 3,382,149
Largest asset managers voting on “Election of the two Class I director nominees to serve until the 2028 Annual Meeting of Stockholders and until” at COGENT BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity16,608,6990 0293For
Vanguard5,988,5430 00For
BlackRock3,807,6570 00For
State Street4,6690 01,823,414Withhold
Charles Schwab832,0630 00For
FRANKLIN STRATEGIC SERIES00 0481,629Withhold
Dimensional00 0278,589Withhold
Equitable164,5700 082,060Mixed
TIAA230,9000 00For
Delaware/Macquarie00 0230,000Withhold
Exchange Place Advisors Trust00 167,3480Abstain
Direxion Shares ETF Trust00 092,566Withhold
Tema ETF Trust72,3700 00For
Lincoln Financial00 070,578Withhold
Global X00 053,448Withhold
ProShares00 053,088Withhold
Northern Trust00 052,044Withhold
AIG/SunAmerica00 046,875Withhold
John Hancock00 34,0420Abstain
Pacific Life29,9220 00For
Nationwide25,8370 00For
Brighthouse00 025,323Withhold
T. Rowe Price21,7740 00For
Bridge Builder Trust19,6000 00For
ETFis Series Trust I00 014,737Withhold

Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).

Elect Director: Matthew E. Ros

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD
FOR: 77,274,345WITHHELD: 13,376,000
Details: description as filed, official tally, votes by 45 asset managers

Description as filed by funds: Election of the two Class I director nominees to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Matthew E. Ros

COGENT BIOSCIENCES INC.’s own tally for this item (“Elect Director: Matthew E. Ros”): 77,274,345 for, 13,376,000 withheld, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, each of the Company's director nominees was elected and each of the other proposals voted on were approved.”
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 30,487,797 for, 878,597 withheld, 56,489 abstained.

FOR
FOR: 30,487,797ABSTAIN: 56,489WITHHOLD: 878,597
Largest asset managers voting on “Election of the two Class I director nominees to serve until the 2028 Annual Meeting of Stockholders and until” at COGENT BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity16,608,6990 0293For
Vanguard5,988,5430 00For
BlackRock3,807,6570 00For
State Street1,825,8020 02,281For
Charles Schwab832,0630 00For
FRANKLIN STRATEGIC SERIES481,6290 00For
Dimensional00 0278,589Withhold
Equitable164,5700 082,060Mixed
TIAA230,9000 00For
Delaware/Macquarie00 0230,000Withhold
Exchange Place Advisors Trust159,2210 8,1270For
Direxion Shares ETF Trust00 092,566Withhold
Tema ETF Trust72,3700 00For
Lincoln Financial68,1000 02,478For
Global X53,4480 00For
ProShares00 053,088Withhold
Northern Trust52,0440 00For
AIG/SunAmerica00 046,875Withhold
John Hancock00 34,0420Abstain
Pacific Life29,9220 00For
Nationwide25,8370 00For
Brighthouse00 025,323Withhold
T. Rowe Price21,7740 00For
Bridge Builder Trust19,6000 00For
ETFis Series Trust I00 014,737Withhold

Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).

Approval of an Amendment to the Certificate of Incorporation to Provide for Officer Exculpation

Calculated outcomeSHAREHOLDER RIGHTS AND DEFENSESPassed (calculated)

95% Majority: yes · of votes cast

FOR 95%
FOR: 86,181,373AGAINST: 4,422,462
Details: description as filed, official tally, votes by 45 asset managers

Description as filed by funds: APPROVAL OF AN AMENDMENT OF THE COMPANY'S CERTIFICATE OF INCORPORATION TO PROVIDE FOR OFFICER EXCULPATION.

COGENT BIOSCIENCES INC.’s own tally for this item (“4. Approval of an Amendment to the Certificate of Incorporation to Provide for Officer Exculpation”): 86,181,373 for, 4,422,462 against, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 30,710,800 for, 712,083 against.

FOR
FOR: 30,710,800AGAINST: 712,083
Largest asset managers voting on “APPROVAL OF AN AMENDMENT OF THE COMPANY'S CERTIFICATE OF INCORPORATION TO PROVIDE FOR OFFICER EXCULPATION.” at COGENT BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity16,608,9920 00For
Vanguard5,988,5430 00For
BlackRock3,807,6570 00For
State Street1,827,401682 00For
Charles Schwab832,0630 00For
FRANKLIN STRATEGIC SERIES0481,629 00Against
Dimensional278,5890 00For
Equitable246,6300 00For
TIAA230,9000 00For
Delaware/Macquarie230,0000 00For
Exchange Place Advisors Trust8,127159,221 00Against
Direxion Shares ETF Trust92,5660 00For
Tema ETF Trust72,3700 00For
Lincoln Financial70,5780 00For
Global X053,448 00Against
ProShares53,0880 00For
Northern Trust52,0440 00For
AIG/SunAmerica46,8750 00For
John Hancock34,0420 00For
Pacific Life29,9220 00For
Nationwide23,0772,760 00Mixed
Brighthouse25,3230 00For
T. Rowe Price21,7740 00For
Bridge Builder Trust19,6000 00For
ETFis Series Trust I14,7370 00For

Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).

Advisory Vote on Executive Compensation

Calculated outcomeFund totals may overlapSECTION 14A SAY-ON-PAY VOTESPassed (calculated)

Combines 8 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 89,797,699AGAINST: 808,715

Prior year: 91.2% for (June 5, 2024 meeting) ▲ 7.9 pts

Details: description as filed, official tally, votes by 173 asset managers

Description as filed by funds: Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.

COGENT BIOSCIENCES INC.’s own tally for this item (“3. Advisory Vote on Executive Compensation”): 89,797,699 for, 808,715 against, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 45 asset managers voting on “Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.” at COGENT BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity16,608,9920 00For
Vanguard5,988,5430 00For
BlackRock3,807,6570 00For
State Street1,827,562521 00For
Charles Schwab832,0630 00For
FRANKLIN STRATEGIC SERIES481,6290 00For
Dimensional278,5890 00For
Equitable246,6300 00For
TIAA230,9000 00For
Delaware/Macquarie230,0000 00For
Exchange Place Advisors Trust167,3480 00For
Direxion Shares ETF Trust92,5660 00For
Tema ETF Trust72,3700 00For
Lincoln Financial70,5780 00For
Global X53,4480 00For
ProShares53,0880 00For
Northern Trust52,0440 00For
AIG/SunAmerica46,8750 00For
John Hancock34,0420 00For
Pacific Life29,9220 00For
Nationwide25,8370 00For
Brighthouse25,3230 00For
T. Rowe Price21,7740 00For
Bridge Builder Trust19,6000 00For
ETFis Series Trust I14,7370 00For

Fund voting reports, all 45 managers: 31,410,885 for, 11,998 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 142 asset managers voting on “Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.” at COGENT BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity16,801,7280 00For
Paradigm Biocapital Advisors LP8,315,8780 00For
Commodore Capital LP8,147,1560 00For
TCG Crossover Management, LLC6,964,3750 00For
Kynam Capital Management, LP00 06,690,128Withhold
Fairmount Funds Management LLC6,225,6410 00For
VR Adviser, LLC5,684,4110 00For
State Street3,497,655745 00For
BlackRock3,391,86820,812 00For
Octagon Capital Advisors LP2,763,0000 00For
DEERFIELD MANAGEMENT COMPANY, L.P.2,640,2140 00For
GEODE CAPITAL MANAGEMENT, LLC2,405,6460 00For
Redmile Group, LLC2,310,6260 00For
Vestal Point Capital, LP1,943,9310 00For
Frazier Life Sciences Management, L.P.1,737,6010 00For
Woodline Partners LP1,646,8010 00For
Nantahala Capital Management, LLC1,497,3870 00For
Sofinnova Investments, Inc.1,431,7700 00For
FRANKLIN ADVISERS INC1,326,3820 00For
Vivo Capital, LLC1,122,4710 00For
Charles Schwab834,7710 00For
Northern Trust740,4000 00For
Saturn V Capital Management LP665,3060 00For
Point72653,1590 00For
Exome Asset Management LLC489,1980 00For

No total is shown for the institutional-manager reports: their sum exceeds the total votes cast at the meeting. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm

Calculated outcomeAUDIT-RELATEDPassed (calculated)

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 101,115,649AGAINST: 104,268

Prior year: 99.9% for (June 5, 2024 meeting) unchanged

Details: description as filed, official tally, votes by 45 asset managers

Description as filed by funds: Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.

COGENT BIOSCIENCES INC.’s own tally for this item (“2. Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm”): 101,115,649 for, 104,268 against, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 45 asset managers below reported 31,422,171 for, 712 against.

FOR
FOR: 31,422,171AGAINST: 712
Largest asset managers voting on “Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public acc” at COGENT BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity16,608,9920 00For
Vanguard5,988,5430 00For
BlackRock3,807,6570 00For
State Street1,827,99390 00For
Charles Schwab832,0630 00For
FRANKLIN STRATEGIC SERIES481,6290 00For
Dimensional278,5890 00For
Equitable246,6300 00For
TIAA230,9000 00For
Delaware/Macquarie230,0000 00For
Exchange Place Advisors Trust167,3480 00For
Direxion Shares ETF Trust92,5660 00For
Tema ETF Trust72,3700 00For
Lincoln Financial70,5780 00For
Global X53,4480 00For
ProShares53,0880 00For
Northern Trust52,0440 00For
AIG/SunAmerica46,8750 00For
John Hancock34,0420 00For
Pacific Life29,9220 00For
Nationwide25,8370 00For
Brighthouse25,3230 00For
T. Rowe Price21,7740 00For
Bridge Builder Trust19,6000 00For
ETFis Series Trust I14,7370 00For

Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).

Largest COGENT BIOSCIENCES INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 113,856,454 shares outstanding at the time of that meeting.

Fund voting reports: top COGENT BIOSCIENCES INC. shareholders by shares voted on “Approval, on a non-binding, advisory basis, of the compensation of the Company's named…”, 2024-2025
#Asset manager % of shares outstanding
1Fidelity 14.59%
2Vanguard 5.26%
3BlackRock 3.34%
4State Street 1.61%
5Charles Schwab 0.73%
6FRANKLIN STRATEGIC SERIES 0.42%
7Dimensional 0.24%
8Equitable 0.22%
9TIAA 0.20%
10Delaware/Macquarie 0.20%
Institutional-manager reports: top COGENT BIOSCIENCES INC. shareholders by shares voted on “Approval, on a non-binding, advisory basis, of the compensation of the Company's named…”, 2024-2025
#Asset manager % of shares outstanding
1Fidelity 14.76%
2Paradigm Biocapital Advisors LP 7.30%
3Commodore Capital LP 7.16%
4TCG Crossover Management, LLC 6.12%
5Kynam Capital Management, LP 5.88%
6Fairmount Funds Management LLC 5.47%
7VR Adviser, LLC 4.99%
8State Street 3.07%
9BlackRock 3.00%
10Octagon Capital Advisors LP 2.43%

Reported COGENT BIOSCIENCES INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

COGENT BIOSCIENCES INC. holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
FMR (Fidelity)17,077,329 —Form 13F, quarter ended March 31, 2025
Entities affiliated with FMR LLC16,569,256 —Proxy statement (DEF 14A), proxy filed April 22, 2025
Fairmount Funds Management LLC15,356,918 —Schedule 13D, filed March 31, 2026
Entities affiliated with Fairmount Funds Management LLC11,825,641 —Proxy statement (DEF 14A), proxy filed April 22, 2025
Entities affiliated with Commodore Capital LP10,497,990 —Proxy statement (DEF 14A), proxy filed April 22, 2025
Entities affiliated with Point72 Asset Management, L.P.9,986,132 —Proxy statement (DEF 14A), proxy filed April 22, 2025
Entities affiliated with Kynam Capital Management, LP9,239,731 —Proxy statement (DEF 14A), proxy filed April 22, 2025
Deerfield Mgmt, L.P.9,043,903 —Schedule 13G, filed May 14, 2026
BlackRock8,175,527 —Form 13F, quarter ended March 31, 2025
Entities affiliated with TCG Crossover Fund I, L.P.6,964,375 —Proxy statement (DEF 14A), proxy filed April 22, 2025

Percentages above are of 113,856,454 shares outstanding, as reported by COGENT BIOSCIENCES INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At COGENT BIOSCIENCES INC.'s shareholder meeting held June 4, 2025, in the 2024-2025 proxy season, 173 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 935 separate fund positions. On the most widely held item on that ballot — Approval, on a non-binding, advisory basis, of the compensation of the Company's named… — FOR was 99.1% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: COGENT BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 5, 2025.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from COGENT BIOSCIENCES INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

COGENT BIOSCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Cite this page

Proxy Votes Now, “COGENT BIOSCIENCES (COGT) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/cogent-biosciences-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.